BlackRock Health Sciences Trust (NYSE:BME) Plans Monthly Dividend of $0.26

BlackRock Health Sciences Trust (NYSE:BME) announced a monthly dividend on Friday, February 27th. Shareholders of record on Monday, June 15th will be paid a dividend of 0.2621 per share on Tuesday, June 30th. This represents a c) dividend on an annualized basis and a yield of 7.7%. The ex-dividend date is Monday, June 15th.

BlackRock Health Sciences Trust Stock Down 0.1%

BME stock traded down $0.05 during mid-day trading on Friday, hitting $40.85. The company had a trading volume of 45,576 shares, compared to its average volume of 45,281. BlackRock Health Sciences Trust has a 12-month low of $35.03 and a 12-month high of $42.74. The company has a 50-day moving average price of $39.48 and a 200 day moving average price of $40.56.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

A number of hedge funds have recently made changes to their positions in BME. Northwestern Mutual Wealth Management Co. boosted its stake in BlackRock Health Sciences Trust by 285,436.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after buying an additional 4,044,638 shares during the last quarter. 1607 Capital Partners LLC increased its stake in BlackRock Health Sciences Trust by 49.5% in the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock worth $9,429,000 after acquiring an additional 75,958 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of BlackRock Health Sciences Trust by 18.8% during the 3rd quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock worth $8,057,000 after acquiring an additional 34,218 shares in the last quarter. Royal Bank of Canada raised its holdings in shares of BlackRock Health Sciences Trust by 13.0% during the 4th quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock worth $6,600,000 after acquiring an additional 18,442 shares in the last quarter. Finally, Consolidated Portfolio Review Corp boosted its position in shares of BlackRock Health Sciences Trust by 40.2% during the 3rd quarter. Consolidated Portfolio Review Corp now owns 54,522 shares of the company’s stock valued at $2,030,000 after acquiring an additional 15,643 shares during the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.